BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31961880)

  • 1. Between-tumor and within-tumor heterogeneity in invasive potential.
    Padmanaban V; Tsehay Y; Cheung KJ; Ewald AJ; Bader JS
    PLoS Comput Biol; 2020 Jan; 16(1):e1007464. PubMed ID: 31961880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness.
    Chandhoke AS; Chanda A; Karve K; Deng L; Bonni S
    Oncotarget; 2017 Mar; 8(13):21001-21014. PubMed ID: 28423498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
    Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
    Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
    Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
    Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collective invasion in breast cancer requires a conserved basal epithelial program.
    Cheung KJ; Gabrielson E; Werb Z; Ewald AJ
    Cell; 2013 Dec; 155(7):1639-51. PubMed ID: 24332913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of organoid cultured human breast cancer.
    Goldhammer N; Kim J; Timmermans-Wielenga V; Petersen OW
    Breast Cancer Res; 2019 Dec; 21(1):141. PubMed ID: 31829259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Action of Discoidin Domain Receptor 2 in Basal Tumor Cells and Stromal Cancer-Associated Fibroblasts Is Critical for Breast Cancer Metastasis.
    Corsa CA; Brenot A; Grither WR; Van Hove S; Loza AJ; Zhang K; Ponik SM; Liu Y; DeNardo DG; Eliceiri KW; Keely PJ; Longmore GD
    Cell Rep; 2016 Jun; 15(11):2510-23. PubMed ID: 27264173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.
    Sachs N; de Ligt J; Kopper O; Gogola E; Bounova G; Weeber F; Balgobind AV; Wind K; Gracanin A; Begthel H; Korving J; van Boxtel R; Duarte AA; Lelieveld D; van Hoeck A; Ernst RF; Blokzijl F; Nijman IJ; Hoogstraat M; van de Ven M; Egan DA; Zinzalla V; Moll J; Boj SF; Voest EE; Wessels L; van Diest PJ; Rottenberg S; Vries RGJ; Cuppen E; Clevers H
    Cell; 2018 Jan; 172(1-2):373-386.e10. PubMed ID: 29224780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer.
    Roelofs C; Hollande F; Redvers R; Anderson RL; Merino D
    Biochem Soc Trans; 2019 Feb; 47(1):109-117. PubMed ID: 30626705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis.
    Hazan RB; Phillips GR; Qiao RF; Norton L; Aaronson SA
    J Cell Biol; 2000 Feb; 148(4):779-90. PubMed ID: 10684258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 mutation influences progesterone response in human benign mammary organoids.
    Davaadelger B; Choi MR; Singhal H; Clare SE; Khan SA; Kim JJ
    Breast Cancer Res; 2019 Nov; 21(1):124. PubMed ID: 31771627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the molecular basis of breast cancer metastasis with mouse models.
    Vernon AE; Bakewell SJ; Chodosh LA
    Rev Endocr Metab Disord; 2007 Sep; 8(3):199-213. PubMed ID: 17657606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer.
    Chung MJ; Jung SH; Lee BJ; Kang MJ; Lee DG
    Pathol Int; 2004 Jan; 54(1):10-5. PubMed ID: 14674989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo.
    Hubert CG; Rivera M; Spangler LC; Wu Q; Mack SC; Prager BC; Couce M; McLendon RE; Sloan AE; Rich JN
    Cancer Res; 2016 Apr; 76(8):2465-77. PubMed ID: 26896279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential application of organoids in breast cancer research and treatment.
    Ebrahimi N; Nasr Esfahani A; Samizade S; Mansouri A; Ghanaatian M; Adelian S; Shadman Manesh V; Hamblin MR
    Hum Genet; 2022 Feb; 141(2):193-208. PubMed ID: 34713317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
    Cao W; Liu J; Wang L; Li M; Verstegen MMA; Yin Y; Ma B; Chen K; Bolkestein M; Sprengers D; van der Laan LJW; Doukas M; Kwekkeboom J; Smits R; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2019 Mar; 40(1):145-154. PubMed ID: 30289434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-based profiling and deep learning reveal morphological heterogeneity of colorectal cancer organoids.
    Huang K; Li M; Li Q; Chen Z; Zhang Y; Gu Z
    Comput Biol Med; 2024 May; 173():108322. PubMed ID: 38554658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphophenotypic classification of tumor organoids as an indicator of drug exposure and penetration potential.
    Karolak A; Poonja S; Rejniak KA
    PLoS Comput Biol; 2019 Jul; 15(7):e1007214. PubMed ID: 31310602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.